1. Home
  2. ADVB vs AMTX Comparison

ADVB vs AMTX Comparison

Compare ADVB & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ADVB

Advanced Biomed Inc.

HOLD

Current Price

$3.72

Market Cap

109.2M

Sector

Health Care

ML Signal

HOLD

Logo Aemetis Inc. (DE)

AMTX

Aemetis Inc. (DE)

HOLD

Current Price

$1.42

Market Cap

98.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADVB
AMTX
Founded
2014
2005
Country
United States
United States
Employees
31
N/A
Industry
Medical Specialities
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
109.2M
98.6M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
ADVB
AMTX
Price
$3.72
$1.42
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$17.00
AVG Volume (30 Days)
90.0K
974.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$77,194,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$139.04
P/E Ratio
$1.26
N/A
Revenue Growth
N/A
174.60
52 Week Low
$0.19
$1.22
52 Week High
$4.64
$3.66

Technical Indicators

Market Signals
Indicator
ADVB
AMTX
Relative Strength Index (RSI) 96.59 41.18
Support Level $0.38 $1.27
Resistance Level N/A $1.65
Average True Range (ATR) 0.14 0.09
MACD 0.47 -0.02
Stochastic Oscillator 93.49 1.16

Price Performance

Historical Comparison
ADVB
AMTX

About ADVB Advanced Biomed Inc.

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

About AMTX Aemetis Inc. (DE)

Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.

Share on Social Networks: